Inventor · disambiguated record
Carl Mieczkowski
Also filed as: MIECZKOWSKI CARL
8 granted patents·34 citations·filing 2011–2021
82Inventor score
Top patents by PatentIndex Score
8 records- 0191US10894829B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2020·Granted Jan 19, 2021·3 cites·17 claims
- 0291US10556950B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2018·Granted Feb 11, 2020·9 cites·36 claims
- 0388US11739143B2Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the sameTEIJIN PHARMA LTD·Filed 2020·Granted Aug 29, 2023·2 cites·16 claims
- 0488US9072668B2Non-aqueous high concentration reduced viscosity suspension formulations of antibodiesDAI WEIGUO·Filed 2011·Granted Jul 7, 2015·19 cites·15 claims
- 0583US11702467B2High affinity antibodies targeting tau phosphorylated at serine 413MERCK SHARP & DOHME LLC·Filed 2021·Granted Jul 18, 2023·1 cites·33 claims
- 0671US12441792B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME·Filed 2021·Granted Oct 14, 2025·0 cites·13 claims
- 0771US12435133B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 7, 2025·0 cites·15 claims
- 0869US11111297B2Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Carl Mieczkowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →